Eric C. Jeschke
127 IP cases indexed. Covers patent matters.
Cases Presided Over
127 cases indexed | Page 4 of 5
Eunsung Global Corp. v.HydraFacial LLC et al.
The PTAB denied institution for an IPR challenge regarding skin treatment systems due to substantial overlap with parallel ITC proceedings and advanced litigation. This decision emphasizes resource conservation when multiple venues address the same prior art.
Decent Espresso International Ltd. v.DUVALL ESPRESSO IP ENFORCEMENT, LLC
The PTAB denied Decent Espresso International Ltd.'s IPR challenge against DUVALL ESPRESSO IP ENFORCEMENT, LLC's infused beverage brewing assembly patent. The Board rejected the petitioner's claim construction of 'resulting solvent valve,' upholding the single-valve interpretation required by the patent owner.
Sinclair Pharma Limited et al. v.HydraFacial LLC
Sinclair Pharma Limited et al. successfully instituted IPR proceedings against HydraFacial LLC regarding skin treatment systems, finding a reasonable likelihood of obviousness over prior art references. The Board found that combining existing microdermabrasion and irrigation technologies renders the challenged claims unpatentable.
Imperative Care, Inc. v.Inari Medical, Inc.
Imperative Care challenges Inari Medical's hemostasis valve patents under grounds of anticipation and obviousness. The Board construed the key term 'filament' to require flexibility, which influenced its initial assessment of the claims. Institution was granted, setting the stage for a full trial on infringement and validity.
Kubota North America Corporation et al. v.Vermeer Manufacturing Company
Kubota North America Corporation successfully petitioned for institution in an IPR against Vermeer Manufacturing Company's '386 patent, asserting grounds of obviousness (103) and novelty (102). The Board found that the petitioner's arguments regarding prior art combinations were persuasive enough to overcome the Patent Owner's request for discretionary denial.
Kubota North America Corporation et al. v.Vermeer Manufacturing Company
Kubota North America Corporation successfully navigated the institution decision process against Vermeer Manufacturing Company's patent, leading to a trial on key claims. The Board found that the prior art was sufficiently distinct from previous PTO examinations and granted review under § 325(d).
Kubota North America Corporation et al. v.Vermeer Manufacturing Company
Kubota North America Corporation successfully convinced the PTAB not to issue a discretionary denial of its IPR petition against Vermeer Manufacturing Company's patent. The Board found that Kubota demonstrated a reasonable likelihood of prevailing on at least one ground, allowing the case to proceed to full examination.
Kubota North America Corporation et al. v.Vermeer Manufacturing Company
Kubota North America Corporation successfully petitioned the PTAB, leading to the institution of its IPR against Vermeer Manufacturing Company's patent (9321386). The Board found a reasonable likelihood that at least one claim would be unpatentable based on prior art combinations.
Kubota North America Corporation et al. v.Vermeer Manufacturing Company
Kubota North America Corporation successfully petitioned against Vermeer Manufacturing Company's patent, leading the PTAB to institute trial on all 28 claims. The Board found a reasonable likelihood of prevailing based on anticipation and obviousness grounds using prior art references KR996, Bares, and Beltrami.
Decent Espresso International Ltd. v.DUVALL ESPRESSO IP ENFORCEMENT, LLC
The PTAB denied institution of an IPR for a beverage brewing system patent (11957271), finding that the petitioner failed to show a reasonable likelihood of prevailing. The denial hinged on the Board's determination that key prior art, Buttiker, was not applicable.
Harbor Freight Tools USA, Inc. et al. v.Champion Power Equipment, Inc.
The PTAB institution decision found a reasonable likelihood of unpatentability for the multi-fuel generator patent (10393034). The Board adopted Petitioner's claim construction regarding 'gaseous fuel,' which was critical to establishing obviousness and anticipation grounds.
Generac Power Systems, Inc. et al. v.Champion Power Equipment, Inc.
Generac Power Systems successfully convinced the PTAB to institute IPR proceedings against Champion Power Equipment, Inc., regarding a dual-fuel generator control system. The Board found sufficient showing of obviousness and anticipation across multiple grounds using prior art references like DuroMax and De Vries.
Straumann USA, LLC et al. v.Smart Denture Conversions, LLC.
Straumann USA, LLC successfully petitioned against Smart Denture Conversions, LLC's patent, leading to institution of IPR proceedings. The Board found a reasonable likelihood that claims are unpatentable under both anticipation (102) and obviousness (103).
Imperative Care, Inc. v.Inari Medical, Inc. et al.
Imperative Care successfully challenged the patentability of Inari Medical's hemostasis valve claims before the PTAB, leading to institution on grounds of anticipation and obviousness. The Board focused heavily on claim construction, ultimately defining 'filament' as a flexible length of material necessary for the device function. This decision sets important precedent regarding functional limitations in medical device patents.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
Imperative Care successfully met the institution burden in its IPR against Inari Medical's '333 patent, establishing a reasonable likelihood of prevailing on key claims. The Board found that combining prior art references like Laub and Garrison renders the claimed thromboembolism treatment systems obvious under 103.
MPL Brands NV, Inc. v.BuzzBallz, LLC
MPL Brands NV successfully petitioned for institution of its obviousness challenge against BuzzBallz's beverage container patent (11932441). The Board found that the design application introduced new matter, making the claims eligible for review.
Straumann USA, LLC et al. v.Smart Denture Conversions, LLC.
Straumann USA successfully petitioned for institution in a Post-Grant Review challenging Smart Denture Conversions' dental implant patent (12156781). The Board found likelihood of unpatentability based on indefiniteness and lack of written description/enablement. This sets a precedent regarding the sufficiency of disclosure in complex medical device claims.
Toyota Motor Corporation et al. v.Infogation Corp.
Toyota Motor Corp and Infogation Corp settled their inter partes review dispute before any trial, leading the PTAB to dismiss the proceedings and keep the settlement confidential.
Toyota Motor Corporation et al. v.Infogation Corp.
Toyota and Infogation settled their IPR dispute over patent 6,292,743 B1, leading the Board to dismiss the case before a trial. The settlement agreement is treated as confidential under statutory provisions.
Dyson Technology Limited et al. v.Omachron Intellectual Property Inc. et al.
Dyson and Omachron settled their inter partes review disputes, leading the PTAB to terminate four IPRs involving Dyson patents. The settlement agreement is treated as confidential business information.
Imperative Care, Inc. v.INARI MEDICAL, INC.
Imperative Care has successfully instituted an IPR against Inari Medical’s 11,844,921 B2 hemostasis valve patent, asserting unpatentability under §§102 and 103 based on Schaffer, Hartley, and Eller. The Board found a reasonable likelihood of success and ordered review of all challenged claims.
Imperative Care, Inc. v.INARI MEDICAL, INC.
The PTAB instituted an inter partes review of Inari Medical’s 11,554,005 B2 embolism‑treatment patent after finding Imperative Care’s obviousness arguments sufficiently persuasive.
Dyson Technology Limited et al. v.Omachron Intellectual Property Inc. et al.
Dyson and Omachron settled their IPR dispute before the PTAB could institute a trial, leading to termination of both proceedings and confidential treatment of the settlement agreement.
Imperative Care, Inc. v.Inari Medical, Inc.
Imperative Care has successfully instituted an inter partes review of Inari Medical’s 11,697,011 hemostasis valve patent, asserting anticipation and obviousness over three prior‑art references. The Board found a reasonable likelihood of unpatentability on at least one claim and ordered the trial to proceed.
Imperative Care, Inc. v.Inari Medical, Inc.
The PTAB instituted an inter partes review of Inari Medical’s 11,844,921 B2 hemostasis valve patent after Imperative Care showed a reasonable likelihood of success. All challenged claims (1‑7, 9‑10, 15‑18, 20‑24) are now under review.
Imperative Care, Inc. v.Inari Medical, Inc.
The PTAB held that all nine claims of Inari Medical’s hemostasis‑valve patent are unpatentable. Petitioner Imperative Care proved anticipation and obviousness over Schaffer, Hartley, Eller and Garrison, with the Board emphasizing that the claimed filament must be flexible.
Imperative Care, Inc. v.Inari Medical, Inc.
The PTAB instituted an inter partes review of Inari Medical’s 11,697,012 B2 hemostasis valve patent after finding Imperative Care’s petition shows a reasonable likelihood of success on all nine challenged claims.
Imperative Care, Inc. v.Inari Medical, Inc.
The PTAB has instituted an inter partes review of Inari Medical’s 11,865,291 B2 hemostasis valve patent after finding Imperative Care’s petition shows a reasonable likelihood of success. All challenged claims (1‑8, 12‑19) are now subject to trial.
Eunsung Global Corp. v.HydraFacial LLC et al.
Eunsung Global Corp. and HydraFacial LLC settled their inter partes review disputes, leading the PTAB to terminate both IPRs before institution. The settlement agreement is treated as confidential business information.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
The PTAB held that Imperative Care proved all nine claims of Inari Medical’s 11,697,011 B2 hemostasis valve patent are unpatentable, finding the term “filament” must be flexible and that the prior art renders the claims obvious.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.